Interferon type I responses in primary and secondary infections (Q37052627)

17 August 2017

1 reference

title

Interferon type I responses in primary and secondary infections (English)

1 reference

17 August 2017

Mohammed Alsharifi

1

1 reference

PubMed ID

18180794

17 August 2017

Arno Müllbacher

series ordinal

2

1 reference

PubMed ID

18180794

17 August 2017

Matthias Regner

series ordinal

3

1 reference

17 August 2017

8 January 2008

1 reference

Immunology & Cell Biology

17 August 2017

1 reference

17 August 2017

86

1 reference

17 August 2017

3

1 reference

17 August 2017

239-245

1 reference

Virus interference. I. The interferon

17 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferons and their actions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

IFN-lambda: novel antiviral cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type I interferons and the innate immune response--more than just antiviral cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferons, interferon-like cytokines, and their receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon-delta: the first member of a novel type I interferon family.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Unique features of the trophoblast interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Characterization of the type I interferon locus and identification of novel genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon-kappa, a novel type I interferon expressed in human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The human interferon alpha/beta receptor: characterization and molecular cloning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

STATs and gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Are all type I human interferons equivalent?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

1 reference

7 January 2021

The neglected role of type I interferon in the T-cell response: implications for its clinical use

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The nature of the principal type 1 interferon-producing cells in human blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Links between innate and adaptive immunity via type I interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type I interferons in host defense

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Toll-like receptors and Type I interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

How important are Toll-like receptors for antimicrobial responses?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

IFNs activate toll-like receptor gene expression in viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Species-specific regulation of Toll-like receptor 3 genes in men and mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Immune defence in mice lacking type I and/or type II interferon receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The interferon system: a review with emphasis on the role of PKR in growth control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interleukin-2, interleukin-15, and their roles in human natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Nitric oxide and macrophage function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Natural adjuvants: endogenous activators of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type I interferon dependence of plasmacytoid dendritic cell activation and migration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Specific inhibition of type I interferon signal transduction by respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type I interferons keep activated T cells alive

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon-beta mediates stromal cell rescue of T cells from apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

A unique mechanism for innate cytokine promotion of T cell responses to viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type I interferon-mediated stimulation of T cells by CpG DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

T-cell proliferation in vivo and the role of cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Selective Depletion of Nonspecific T Cells During the Early Stage of Immune Responses to Infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Mechanisms of suppression of cytotoxic T-cell responses in murine lymphocytic choriomeningitis virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

NK cell-mediated immunopathology during an acute viral infection of the CNS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The role of type I interferons in non-viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type I interferons and the Th1/Th2 paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Effects of type I/type II interferons and transforming growth factor-beta on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

IFN-alpha/beta enhances BCR-dependent B cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

CD80 (B7-1) and CD86 (B7-2) antigens on house dust mite-specific T cells in atopic disease function through T-T cell interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Immunogene therapy against mouse leukemia using B7 molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

CD69 is an immunoregulatory molecule induced following activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The emerging role of interferon in human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Attrition of virus-specific memory CD8+ T cells during reconstitution of lymphopenic environments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Exhaustion of type I interferon response following an acute viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Dendritic cells exposed to herpes simplex virus in vivo do not produce IFN-alpha after rechallenge with virus in vitro and exhibit decreased T cell alloreactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Infection of dendritic cells by murine cytomegalovirus induces functional paralysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100159

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100159

1 reference

17 August 2017

1 reference

PubMed ID

18180794